TY - JOUR
T1 - Subcutaneous Adipose Tissue Edema in Lipedema Revealed by Noninvasive 3T MR Lymphangiography
AU - Crescenzi, Rachelle
AU - Donahue, Paula M.C.
AU - Garza, Maria
AU - Patel, Niral J.
AU - Lee, Chelsea
AU - Guerreso, Kelsey
AU - Hall, Greg
AU - Luo, Yu
AU - Chen, Sheau Chiann
AU - Herbst, Karen L.
AU - Pridmore, Michael
AU - Aday, Aaron W.
AU - Beckman, Joshua A.
AU - Donahue, Manus J.
N1 - Funding Information:
The authors are grateful to Dr. Steven Dean, DO, FACP, RPVI for providing clinical photos to demonstrate lipedema and lymphedema symptomatology. Imaging experiments were performed in the Vanderbilt Human Imaging Core, using research resources supported by the National Institutes of Health (NIH) grant 1S10OD021771‐01. The authors are grateful for Philips support from Charles Nockowski and Ryan Robinson, and to core MRI technologists Christopher Thompson, Clair Jones, Marisa Bush, Josh Hageman, and Cori Welliever. Recruitment through www.ResearchMatch.org and services at the Clinical Research Center are supported by the National Center for Advancing Translational Sciences (NCATS) Clinical Translational Science Award (CTSA) Program, award number 5UL1TR002243‐03.
Funding Information:
M.J.D. receives research related support from Philips North America; is a paid consultant for Pfizer Inc, Global Blood Therapeutics, and LymphaTouch; is a paid advisory board member for Novartis and bluebird bio; receives research funding from Pfizer Inc; and is the CEO of biosight, LLC which provides healthcare technology consulting services. A.W.A reports receiving personal fees from OptumCare outside of the current work. J.A.B. reports consulting honoraria for JanOne, Janssen, and Novartis.
Publisher Copyright:
© 2022 International Society for Magnetic Resonance in Medicine.
PY - 2023/2
Y1 - 2023/2
N2 - Background: Lipedema exhibits excessive lower-extremity subcutaneous adipose tissue (SAT) deposition, which is frequently misidentified as obesity until lymphedema presents. MR lymphangiography may have relevance to distinguish lipedema from obesity or lymphedema. Hypothesis: Hyperintensity profiles on 3T MR lymphangiography can identify distinct features consistent with SAT edema in participants with lipedema. Study Type: Prospective cross-sectional study. Subjects: Participants (48 females, matched for age [mean = 44.8 years]) with lipedema (n = 14), lipedema with lymphedema (LWL, n = 12), cancer treatment-related lymphedema (lymphedema, n = 8), and controls without these conditions (n = 14). Field Strength/Sequence: 3T MR lymphangiography (nontracer 3D turbo-spin-echo). Assessment: Review of lymphangiograms in lower extremities by three radiologists was performed independently. Spatial patterns of hyperintense signal within the SAT were scored for extravascular (focal, diffuse, or not apparent) and vascular (linear, dilated, or not apparent) image features. Statistical Tests: Interreader reliability was computed using Fleiss Kappa. Fisher's exact test was used to evaluate the proportion of image features between study groups. Multinomial logistic regression was used to assess the relationship between image features and study groups. The odds ratio (OR) and 95% confidence interval (CI) of SAT extravascular and vascular features was reported in groups compared to lipedema. The threshold of statistical significance was P < 0.05. Results: Reliable agreement was demonstrated between three independent, blinded reviewers (P < 0.001). The frequency of SAT hyperintensities in participants with lipedema (36% focal, 36% diffuse), LWL (42% focal, 33% diffuse), lymphedema (62% focal, 38% diffuse), and controls (43% focal, 0% diffuse) was significantly distinct. Compared with lipedema, SAT hyperintensities were less frequent in controls (focal: OR = 0.63, CI = 0.11–3.41; diffuse: OR = 0.05, CI = 0.00–1.27), similar in LWL (focal: OR = 1.29, CI = 0.19–8.89; diffuse: OR = 1.05, CI = 0.15–7.61), and more frequent in lymphedema (focal: OR = 9.00, CI = 0.30–274.12; diffuse: OR = 5.73, CI = 0.18–186.84). Data Conclusion: Noninvasive MR lymphangiography identifies distinct signal patterns indicating SAT edema and lymphatic load in participants with lipedema. Evidence Level: 1. Technical Efficacy: Stage 1.
AB - Background: Lipedema exhibits excessive lower-extremity subcutaneous adipose tissue (SAT) deposition, which is frequently misidentified as obesity until lymphedema presents. MR lymphangiography may have relevance to distinguish lipedema from obesity or lymphedema. Hypothesis: Hyperintensity profiles on 3T MR lymphangiography can identify distinct features consistent with SAT edema in participants with lipedema. Study Type: Prospective cross-sectional study. Subjects: Participants (48 females, matched for age [mean = 44.8 years]) with lipedema (n = 14), lipedema with lymphedema (LWL, n = 12), cancer treatment-related lymphedema (lymphedema, n = 8), and controls without these conditions (n = 14). Field Strength/Sequence: 3T MR lymphangiography (nontracer 3D turbo-spin-echo). Assessment: Review of lymphangiograms in lower extremities by three radiologists was performed independently. Spatial patterns of hyperintense signal within the SAT were scored for extravascular (focal, diffuse, or not apparent) and vascular (linear, dilated, or not apparent) image features. Statistical Tests: Interreader reliability was computed using Fleiss Kappa. Fisher's exact test was used to evaluate the proportion of image features between study groups. Multinomial logistic regression was used to assess the relationship between image features and study groups. The odds ratio (OR) and 95% confidence interval (CI) of SAT extravascular and vascular features was reported in groups compared to lipedema. The threshold of statistical significance was P < 0.05. Results: Reliable agreement was demonstrated between three independent, blinded reviewers (P < 0.001). The frequency of SAT hyperintensities in participants with lipedema (36% focal, 36% diffuse), LWL (42% focal, 33% diffuse), lymphedema (62% focal, 38% diffuse), and controls (43% focal, 0% diffuse) was significantly distinct. Compared with lipedema, SAT hyperintensities were less frequent in controls (focal: OR = 0.63, CI = 0.11–3.41; diffuse: OR = 0.05, CI = 0.00–1.27), similar in LWL (focal: OR = 1.29, CI = 0.19–8.89; diffuse: OR = 1.05, CI = 0.15–7.61), and more frequent in lymphedema (focal: OR = 9.00, CI = 0.30–274.12; diffuse: OR = 5.73, CI = 0.18–186.84). Data Conclusion: Noninvasive MR lymphangiography identifies distinct signal patterns indicating SAT edema and lymphatic load in participants with lipedema. Evidence Level: 1. Technical Efficacy: Stage 1.
KW - lipedema
KW - lipoedema
KW - lymphangiography
KW - lymphedema
KW - obesity
UR - http://www.scopus.com/inward/record.url?scp=85131183473&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131183473&partnerID=8YFLogxK
U2 - 10.1002/jmri.28281
DO - 10.1002/jmri.28281
M3 - Article
C2 - 35657120
AN - SCOPUS:85131183473
SN - 1053-1807
VL - 57
SP - 598
EP - 608
JO - Journal of Magnetic Resonance Imaging
JF - Journal of Magnetic Resonance Imaging
IS - 2
ER -